NCT02813343
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Women's College Hospital Toronto, Ontario, Canada
Clinical trial condition
Diabetes Mellitus, Type 2
Explore clinical trials studying Diabetes Mellitus, Type 2. Study availability and eligibility vary by location and protocol.
8,005 public trials
713 recruiting studies
Diabetes Mellitus, Type 2 trial results
NCT02192853
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Diabetes Research Division, Department of Endocrinology, Gentofte Hospital Hellerup, Denmark
NCT00615212
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
Completed
Injection Site Study In Patients With Type 2 Diabetes Mellitus (T2DM) And Healthy Volunteers
NCT00394030
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Long Beach, California, United States
- GSK Investigational Site Walnut Creek, California, United States
- GSK Investigational Site Miramar, Florida, United States
- GSK Investigational Site Orlando, Florida, United States
NCT01095666
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +4 more
- Locations
-
- Local Institution Hefei, Anhui, China
- Local Institution Beijing, Beijing Municipality, China
- Local Institution Beijing, Beijing Municipality, China
- Local Institution Beijing, Beijing Municipality, China
Completed
First-Time-in-Humans Study to Assess Safety, Pharmacokinetics & Pharmacodynamics of SB756050
NCT00607906
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Minneapolis, Minnesota, United States
NCT00519480
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
- GSK Investigational Site Miami, Florida, United States
- GSK Investigational Site San Antonio, Texas, United States
- GSK Investigational Site Buenos Aires, Argentina
- GSK Investigational Site Berlin, Germany
NCT03272074
- Conditions
- Body Weight, Diabetes Mellitus, Diabetes Mellitus, Type 2, +13 more
- Locations
-
- Florida State University Tallahassee, Florida, United States
Completed
Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®)
NCT02321878
- Conditions
- Diabetes, Diabetes Mellitus, Diabetes Mellitus, Type 2, +4 more
- Locations
-
- Novo Nordisk Investigational Site Chichibu, Japan
- Novo Nordisk Investigational Site Koriyama-shi, Fukushima, Japan
- Novo Nordisk Investigational Site Oyama-shi, Tochigi, Japan
- Novo Nordisk Investigational Site Tagajō-shi, Japan
NCT02857764
- Conditions
- Diabetes Mellitus, Diabetes Mellitus, Type 2, Endocrine System Diseases, +3 more
- Locations
-
Not specified